Welcome to our dedicated page for Sally Beauty Hldgs SEC filings (Ticker: SBH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sally Beauty Holdings, Inc. filings document formal disclosures for a NYSE-listed professional beauty-products retailer with common stock traded under the symbol SBH. Recent Form 8-K reports cover quarterly operating results, Regulation FD updates, strategy and business outlook commentary, earnings-release exhibits, and capital-allocation details such as debt repayment and share repurchases.
The company’s governance filings include Item 5.02 reports on executive and director changes, related compensatory arrangements, and board composition. Proxy and annual meeting records document director elections, advisory votes on executive compensation, auditor ratification, stockholder voting results, and executive compensation disclosures.
Sally Beauty Holdings (SBH) reported insider equity activity for its SVP, CLO and CHRO on Form 4 dated 11/05/2025. The filing lists multiple restricted stock unit (RSU) and performance stock unit (PSU) awards at a price of $0 per unit.
Earned PSUs include 9,301 tied to relative total shareholder return, payable on 11/15/2025, and 3,885 tied to adjusted operating income margin (AOIM) for the third one-year period of a 2022 grant, also payable on 11/15/2025. Additional AOIM-based earned PSUs of 6,610 (from a 2023 grant) are payable on 11/15/2026, and 5,537 (from a 2024 grant) are payable on 11/15/2027.
The officer also received an RSU grant of 29,452 that vests in three equal installments on 11/15/2026, 11/15/2027, and 11/15/2028.
Sally Beauty Holdings (SBH) reported insider equity awards for its President & CEO, who is also a Director, effective 11/05/2025. The Form 4 lists multiple entries coded A at $0 price: an award of 242,550 restricted stock units vesting in three equal installments on 11/15/2026, 11/15/2027, and 11/15/2028; and earned performance stock units converting one-for-one to common stock, including 76,832 rTSR PSUs and 32,088 AOIM PSUs payable on 11/15/2025, plus 57,480 AOIM PSUs payable on 11/15/2026 and 40,605 AOIM PSUs payable on 11/15/2027. All positions are shown as Direct (D) ownership.
Sally Beauty Holdings, Inc. (SBH) director Max R. Rangel purchased 3,500 shares of the company's common stock on 09/04/2025 at a reported price of $14.0684 per share. Following the transaction the reporting person beneficially owned 3,500 shares directly. The Form 4 was signed on behalf of the reporting person by an attorney-in-fact on 09/08/2025. No derivative transactions or additional securities classes are reported.
Debra Golding Perelman, a director of Sally Beauty Holdings, Inc. (SBH), purchased 2,300 shares of SBH common stock on 08/13/2025. The Form 4 reports the shares were acquired at transaction prices ranging from $13.42 to $13.81 per share, with a reported per-share figure of $13.4831 noted on the form. Following the transaction the reporting person beneficially owns 2,300 shares in a direct ownership form. The filing was signed by an attorney-in-fact, Scott Sherman, on 08/14/2025. The form identifies Perelman as a director and the filing was submitted as a one-person Form 4.
Sally Beauty Holdings (SBH) insider Denise Paulonis, who serves as President & CEO and as a director, purchased 4,500 shares of common stock at $11.74 per share, bringing her direct beneficial ownership to 366,865 shares. The transaction is reported on a Form 4 statement of changes in beneficial ownership.
Diana Sue Ferguson, identified as a director of Sally Beauty Holdings (SBH), purchased 2,500 shares of common stock on 08/07/2025 at $12.0197 per share. After the purchase she directly beneficially owned 7,912 shares. No derivative securities were reported on this Form 4.